Covering the Costs of Your Breast Cancer Care

The costs of breast cancer treatment and follow-up care can be a financial strain for some people and their families, even when they have health insurance.

Cost of breast cancer treatment. A 4-year longitudinal study

of health care resources for the treatment of breast cancer. These cost data should be considered within the framework of future cost-effective analysis for screening mammography programs.

Global treatment costs of breast cancer by stage: A systematic review | PLOS ONE

Background Published evidence on treatment costs of breast cancer varies widely in methodology and a global systematic review is lacking. Objectives This study aimed to conduct a systematic review...

Financial Burden of Cancer: Breast Cancer Treatment Cost Statistics | Michigan M

Read findings from Michigan Medicine study into breast cancer treatment costs, which reveals patients report significant financial burdens from cancer treatment.

Mitigating Financial Toxicity in Breast Cancer From Diagnosis to Treatment and R

Breast cancer is the most common cancer affecting women in United States with a significant patient and familial financial burden.Limited resources offer financial support to patients in the form o...

Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lum

Introduction: Breast cancer treatment costs are rising, and identification of high-value oncology treatment strategies is increasingly needed. We sought to determine the potential cost...

Cost-effectiveness of Herceptin®: A standard cost model for breast-cancer treatm

Objectives: The objective of this study was to conduct a cost... Methods: A cost model with standard diagnostic and treatment options for breast cancer was set up for a Belgian university...

Breast cancer treatment: Drug Kisqali approval expanded for earlier stage disease

The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said.

Cost-effectiveness analysis of palbociclib for the treatment of ER+/HER2- advanced/metastatic breast canc....

2016 Cost-effectiveness analysis of palbociclib for the treatment of ER+/HER2- advanced/metastatic breast cancer / 이의경 연구과제 수정 지우기 Cost-effectiveness analysis of palbociclib for the...

Breast cancer treatment costs in younger, privately insured women | Breast Cancer Research and Treatment

Younger women (under age 45 years) diagnosed with breast cancer often face more aggressive tumors, higher treatment intensity, lower survival rate